过表达组蛋白去乙酰化酶4抑制人结直肠癌细胞系的增殖及侵袭

doi:10.16352/j.issn.1001-6325.2026.08.1051

基础医学与临床 ›› 2026, Vol. 46 ›› Issue (8): 1051-1058.doi: 10.16352/j.issn.1001-6325.2026.08.1051

过表达组蛋白去乙酰化酶4抑制人结直肠癌细胞系的增殖及侵袭

刘获晞^#, 黄柏添^#, 赵云焘, 张家洋, 吴文梅^*

广东药科大学生命科学与生物制药学院,广东广州 510006

收稿日期:2025-05-21 修回日期:2025-09-24 出版日期:2026-08-05 发布日期:2026-07-22
通讯作者: ^*wuwenmei@gdpu.edu.cn
作者简介:^#对本文有相同贡献
基金资助:
国家自然科学基金青年项目(32400410);广东省中医药科研项目(20251216);广东省大学生创新创业训练项目(S202510573010)

Overexpression of histone deacetylase 4 inhibits proliferation and invasion of colorectal cancer cells

LIU Huoxi^#, HUANG Botian^#, ZHAO Yuntao, ZHANG Jiayang, WU Wenmei^*

School of Life Sciences and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou 510006, China

Received:2025-05-21 Revised:2025-09-24 Online:2026-08-05 Published:2026-07-22
Contact: ^*wuwenmei@gdpu.edu.cn

摘要/Abstract

摘要： 目的研究过表达组蛋白去乙酰化酶4(HDAC4)对人结直肠癌细胞系的增殖和侵袭影响。方法基于TCGA、GTEx和HPA公共数据库分析HDAC4在人结直肠癌中的表达水平及其与患者预后的相关性;慢病毒感染技术构建稳定过表达组蛋白去乙酰化酶4的人结直肠癌细胞系SW480和HCT116,利用RT-qPCR和Western blot验证感染效率;CCK-8、EdU、细胞集落形成和Transwell等检测过表达HDAC4对人结直肠癌细胞系的增殖和侵袭作用。结果数据库分析显示HDAC4在人结直肠癌组织中显著低表达,与患者不良预后密切相关,且HPA临床免疫组化样本验证进一步证实HDAC4在结直肠癌组织中的表达水平显著低于正常结直肠组织;RT-qPCR及Western blot实验结果显示成功构建稳定过表达HDAC4的人结直肠癌细胞系SW480和HCT116;过表达HDAC4降低人结直肠癌细胞的活力(P＜0.001)、阳性细胞数(P＜0.01)、集落形成数(P＜0.001);增殖相关基因PCNA(P＜0.01)和MK167(P＜0.01)显著下调;此外,过表达HDAC4使人结直肠癌细胞系的侵袭能力减弱(P＜0.001)。结论过表达HDAC4能够抑制人结直肠癌细胞系的增殖和侵袭,为人结直肠癌的精准治疗提供了新的理论支持和实验依据。

关键词: 人结直肠癌, 组蛋白去乙酰化酶4, 细胞增殖和侵袭, 生物标记物

Abstract: Objective To investigate the regulatory role of histone deacetylase 4(HDAC4) overexpression in the proliferation and invasion of human colorectal cancer (CRC) cells. Methods The expression level of HDAC4 in CRC and its correlation with patient prognosis were analyzed using TCGA, GTEx, and HPA databases. Lentiviral transfection was used to construct HDAC4 overexpressing CRC cell lines (SW480 and HCT116), with transfection efficiency verified by RT-qPCR and Western blot. The effects of HDAC4 overexpression on CRC cell proliferation and invasion were assessed using CCK-8, EdU, colony formation, and Transwell assays. Results Database analysis revealed that HDAC4 was significantly downregulated in human CRC tissues and closely associated with poor patient prognosis. Immunohistochemical validation using HPA clinical samples further confirmed that HDAC4 expression was markedly lower in CRC tissues compared to normal colorectal tissues. RT-qPCR and Western blot confirmed the successful establishment of stable HDAC4 overexpressing SW480 and HCT116 cells. HDAC4 overexpression reduced CRC cell viability (P＜0.001), decreased the number of EdU-positive cells (P＜0.01), and significantly inhibited colony formation (P＜0.001). Additionally, HDAC4 overexpression downregulated the expression of proliferation-related genes PCNA(P＜0.01) and MK167(P＜0.01) and significantly impaired cell invasion ability. Conclusions HDAC4 overexpression suppresses the proliferation and invasion of human CRC cells, providing new theoretical and experimental support for precision therapy in colorectal cancer.

Key words: colorectal cancer, histone deacetylase 4, cell proliferation and invasion, biomarker

中图分类号:

R735.3

刘获晞, 黄柏添, 赵云焘, 张家洋, 吴文梅. 过表达组蛋白去乙酰化酶4抑制人结直肠癌细胞系的增殖及侵袭[J]. 基础医学与临床, 2026, 46(8): 1051-1058.

LIU Huoxi, HUANG Botian, ZHAO Yuntao, ZHANG Jiayang, WU Wenmei. Overexpression of histone deacetylase 4 inhibits proliferation and invasion of colorectal cancer cells[J]. Basic & Clinical Medicine, 2026, 46(8): 1051-1058.

参考文献

[1] 叶小帆, 赵云焘, 刘奕峰, 等. 组蛋白去乙酰化酶4与乳腺癌关系的研究进展[J]. 癌症进展, 2023, 21:1515-1517.
[2] Zhao L, Chen H, Zhang Q, et al. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy[J]. Cancer Chemother Pharmacol, 2022, 89:595-607.
[3] Zang WJ, Hu YL, Qian CY, et al. HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3[J]. Br J Cancer, 2022, 127:237-248.
[4] Wu H, Liu C, Yang Q, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4[J]. Autophagy, 2020, 16:683-697.
[5] Shao C, Guo K, Xu L, et al. Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer[J]. Transl Lung Cancer Res, 2021, 10:4558-4573.
[6] Mansouri N, Alivand MR, Bayat S, et al. The hopeful anti-cancer role of oleuropein in breast cancer through histonedeacetylase modulation[J]. Cell Biochem, 2019, 120:17042-17049.
[7] Sun X, Zhang K, Peng X, et al. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma[J]. Cancer Lett, 2023, 562:216158.doi:10.1016/j.canlet.2023.216158.
[8] Wang T, Lu Z, Han T, et al. Deacetylation of glutaminase by HDAC4 contributes to lung cancer tumorigenesis[J]. Int J Biol Sci, 2022, 18:4452-4465.
[9] Zhao J, Bai H, Li X, et al. Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer[J]. Signal Transduct Target Ther, 2021, 6:303. doi:10.1038/s41392-021-00714-0.
[10] 周家铭, 邬小凤, 吴远辉, 等. 结直肠癌死亡患者的肿瘤转移部位、发生率及预后[J]. 中山大学学报(医学科学版), 2022, 43:289-296.
[11] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71:209-249.
[12] 果月红, 周凡琦, 吴熙, 等.利用结直肠癌类器官模型评估化疗药物药效[J]. 基础医学与临床,2025,45:456-464.
[13] Yousefi H, Vatanmakanian M, Mahdiannasser M, et al. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance[J]. Oncogene, 2021, 40:1043-1063.
[14] Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73:233-254.
[15] Wang Z, Qin G, Zhao TC. HDAC4: mechanism of regulation and biological functions[J]. Epigenomics, 2014, 6:139-150.

过表达组蛋白去乙酰化酶4抑制人结直肠癌细胞系的增殖及侵袭

Overexpression of histone deacetylase 4 inhibits proliferation and invasion of colorectal cancer cells

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	李庆菊, 于然, 陈佳佳, 陈皓瑜, 宋坚, 王万鹏. 雷帕霉素减轻碘佛醇诱导的模型大鼠急性肾损伤[J]. 基础医学与临床, 2024, 44(1): 31-36.
[2]	肖前仁黄路张中卒张战民陈少卿舒勇曹凯. RNA干扰组蛋白去乙酰化酶4抑制骨肉瘤细胞诱导凋亡[J]. 基础医学与临床, 2016, 36(12): 1693-1698.
[3]	曹美群孙珂焕吴安民陈德珩吴正治. 应用iTRAQ定量蛋白质组学方法筛选乳腺癌患者血清差异表达蛋白[J]. 基础医学与临床, 2014, 34(8): 1054-1058.